Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Feb'26
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Aug'24
Net Sales
11,591.00
12,130.00
13,011.00
14,034.00
12,025.00
11,906.00
12,678.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11,591.00
12,130.00
13,011.00
14,034.00
12,025.00
11,906.00
12,678.00
Raw Material Cost
9,239.00
9,923.00
10,453.00
11,772.00
10,028.00
9,777.00
10,428.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
33.00
33.00
30.00
38.00
34.00
34.00
17.00
Selling and Distribution Expenses
1,226.00
1,580.00
1,558.00
1,510.00
1,600.00
1,507.00
1,400.00
Other Expenses
-3.30
-3.30
-3.00
-3.80
-3.40
-3.40
-1.70
Total Expenditure (Excl Depreciation)
10,465.00
11,503.00
12,011.00
13,282.00
11,628.00
11,284.00
11,828.00
Operating Profit (PBDIT) excl Other Income
1126
627
1000
752
397
622
850
Other Income
343.00
182.00
9.00
-1.00
37.00
-101.00
558.00
Operating Profit (PBDIT)
2,612.00
1,897.00
2,051.00
1,875.00
1,539.00
1,582.00
2,450.00
Interest
33.00
33.00
30.00
38.00
34.00
34.00
17.00
Exceptional Items
0.00
2.00
76.00
-164.00
129.00
2.00
0.00
Gross Profit (PBDT)
2,352.00
2,207.00
2,558.00
2,262.00
1,997.00
2,129.00
2,250.00
Depreciation
1,143.00
1,088.00
1,042.00
1,124.00
1,105.00
1,061.00
1,042.00
Profit Before Tax
1,435.00
780.00
1,054.00
549.00
530.00
487.00
1,392.00
Tax
386.00
236.00
377.00
-127.00
158.00
247.00
914.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,036.00
536.00
696.00
691.00
309.00
291.00
617.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,036.00
536.00
696.00
691.00
309.00
291.00
617.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.00
8.00
-20.00
-16.00
63.00
-50.00
-140.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,050.00
544.00
676.00
675.00
372.00
241.00
477.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
52,262.00
52,168.00
52,173.00
52,003.00
51,530.00
52,013.00
52,003.00
Earnings per share (EPS)
35.2
18.11
23.21
22.87
10.16
9.48
20.21
Diluted Earnings per share
35.2
18.11
23.21
22.87
10.16
9.48
20.21
Operating Profit Margin (Excl OI)
9.71%
5.17%
7.69%
5.36%
3.3%
5.22%
6.7%
Gross Profit Margin
22.24%
15.4%
16.11%
11.92%
13.6%
13.0%
19.2%
PAT Margin
8.94%
4.42%
5.35%
4.92%
2.57%
2.44%
4.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Feb 2026 is -3.61% vs 13.96% in Feb 2025
Consolidate Net Profit
YoY Growth in quarter ended Feb 2026 is 182.26% vs -52.06% in Feb 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Feb 2026 is 51.07% vs -12.52% in Feb 2025
Interest
YoY Growth in quarter ended Feb 2026 is -2.94% vs 161.54% in Feb 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Feb 2026 has improved from Feb 2025
Compare Quarterly Results Of Daito Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
11,591.00
0.00
11,591.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
11,591.00
0.00
11,591.00
Raw Material Cost
9,239.00
2.28
9,236.72
405,119.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
33.00
9.08
23.92
263.44%
Selling and Distribution Expenses
1,226.00
360.58
865.42
240.01%
Other Expenses
-3.30
74.89
-78.19
-104.41%
Total Expenditure (Excl Depreciation)
10,465.00
1,120.84
9,344.16
833.67%
Operating Profit (PBDIT) excl Other Income
1,126.00
-1,120.84
2,246.84
200.46%
Other Income
343.00
-2.27
345.27
15,210.13%
Operating Profit (PBDIT)
2,612.00
-1,120.83
3,732.83
333.04%
Interest
33.00
9.08
23.92
263.44%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,352.00
-2.28
2,354.28
103,257.89%
Depreciation
1,143.00
2.28
1,140.72
50,031.58%
Profit Before Tax
1,435.00
-1,132.19
2,567.19
226.75%
Tax
386.00
-3.47
389.47
11,223.92%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,036.00
-1,128.72
2,164.72
191.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,036.00
-1,128.72
2,164.72
191.79%
Share in Profit of Associates
0
0
0.00
Minority Interest
14.00
0.00
14.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,050.00
-1,128.72
2,178.72
193.03%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
52,262.00
13,604.67
38,657.33
284.15%
Earnings per share (EPS)
35.20
-14.81
50.01
337.68%
Diluted Earnings per share
35.20
-14.81
50.01
337.68%
Operating Profit Margin (Excl OI)
9.71%
0.00%
0.00
9.71%
Gross Profit Margin
22.24%
0.00%
0.00
22.24%
PAT Margin
8.94%
0.00%
0.00
8.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,159.10 Million
in Feb 2026Figures in Million
QoQ Growth in quarter ended Feb 2026 is -4.44% vs -6.77% in Nov 2025
YoY Growth in quarter ended Feb 2026 is -3.61% vs 13.96% in Feb 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 105.00 Million
in Feb 2026Figures in Million
QoQ Growth in quarter ended Feb 2026 is 93.01% vs -19.53% in Nov 2025
YoY Growth in quarter ended Feb 2026 is 182.26% vs -52.06% in Feb 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 226.90 Million
in Feb 2026Figures in Million
QoQ Growth in quarter ended Feb 2026 is 32.30% vs -16.01% in Nov 2025
YoY Growth in quarter ended Feb 2026 is 51.07% vs -12.52% in Feb 2025
Quarterly - Interest
Interest 3.30 Million
in Feb 2026Figures in Million
QoQ Growth in quarter ended Feb 2026 is 0.00% vs 10.00% in Nov 2025
YoY Growth in quarter ended Feb 2026 is -2.94% vs 161.54% in Feb 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.71%
in Feb 2026Figures in %
QoQ Growth in quarter ended Feb 2026 has improved from Nov 2025
YoY Growth in quarter ended Feb 2026 has improved from Feb 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
